Skip to main content

Table 3 Bivariate logistic regression model with odds of use of BB-CAM, adjusted for selected patients´ characteristics

From: Use of biologically-based complementary medicine in breast and gynecological cancer patients during systemic therapy

CHARACTERISTICS

BB-CAM USE

Odds ratio

95% CI

p

 

Lower

Upper

 

Age (years)

 ≤60 yrs.

 

1.00 (Reference)

   

 >60 yrs.

 

.612

.385

.972

.038

Therapy

 Bisphosphonates

No medication

1.00 (Reference)

   

Medication

.975

.532

1.787

.934

 Antibodies

No medication

1.00 (Reference)

   

Medication

.875

.503

1.521

.635

 Endocrine

No medication

1.00 (Reference)

   

Medication

1.018

.547

1.895

.955

 Chemotherapy

No medication

1.00 (Reference)

   

Medication

1.576

.879

2.824

.126

Therapy line

.390

 Breast-Ca

Neoadjuvant

1.00 (Reference)

   

Adjuvant

.766

.316

1.857

 

Metastasis

1st -line

.394

.159

.973

 

Metastasis

2nd -line

.823

.302

2.242

 

Metastasis

3rd -line

1.649

.384

7.073

 

Metastasis

≥4th -line

.948

.355

2.530

 

Recurrence

1st -line

.892

.149

5.320

 

Recurrence

≥2nd -line

.372

.054

2.544

 

 Ovarian-Ca

Adjuvant

1.072

.371

3.099

 

Recurrent

1.035

.363

2.955

 
Back to article page

BMC Complementary Medicine and Therapies

ISSN: 2662-7671

Contact us